![Steven Baert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Baert
Personalreferent bei
GE VERNOVA INC.
Vermögen: 20 Mio $ am 30.06.2026
Profil
Steven Baert is currently Director at Weseehope Usa, Inc., Managing Partner at Propuli GmbH since 2022, Chief People Officer at GE Vernova, Inc. since 2023, and Member of the Supervisory Board at Servier SAS. Former roles include Non-Executive Director at Pharming Group NV from 2021 to 2025, Director at Haleon UK Holdings Ltd. from 2015 to 2018, Principal at Bristol Myers Squibb Co. and Unilever Plc, Head-Human Resources at Novartis Oncology, Inc. from 2012 to 2014, Head-Human Resources Global Functions at Novartis AG from 2006 to 2014, Chief Human Capital Officer at Flagship Pioneering, LLC, Vice President & Head-Human Resources at Novartis Pharmaceuticals Corp.
in 2012, and Head-Human Resources at Novartis Pharma Canada, Inc. Education includes a graduate degree from Katholieke Universiteit Leuven in 1997, an MBA from Vlerick Leuven Gent Management School in 1998, and an undergraduate degree from Hogeschool-Universiteit Brussel in 1994.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GE VERNOVA INC. 0.01% | 03.04.2026 | 17’038 ( 0.01% ) | 20 Mio $ | 30.06.2026 |
Aktive Positionen von Steven Baert
| Unternehmen | Position | Beginn |
|---|---|---|
| GE VERNOVA INC. | Personalreferent | 01.04.2023 |
Weseehope Usa, Inc.
 Weseehope Usa, Inc. Investment Trusts/Mutual FundsMiscellaneous Engages in fundraising to help children from poverty and to provide educational services | Direktor/Vorstandsmitglied | - |
Propuli GmbH | Corporate Officer/Principal | 01.03.2022 |
Servier SAS
 Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Steven Baert
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMING GROUP N.V. | Direktor/Vorstandsmitglied | 11.06.2025 |
| NOVARTIS AG | Personalreferent | 30.06.2021 |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
 GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | 01.01.2018 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01.01.2014 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Personalreferent | 01.07.2012 |
Ausbildung von Steven Baert
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Unilever Plc
 Unilever Plc Household/Personal CareConsumer Non-Durables Provides fast moving consumer goods | Consumer Non-Durables |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlerick Leuven Gent Management School
 Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hogeschool-Universiteit Brussel
 Hogeschool-Universiteit Brussel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Novartis Pharma Canada, Inc. | |
Weseehope Usa, Inc.
Weseehope Usa, Inc. Investment Trusts/Mutual FundsMiscellaneous Engages in fundraising to help children from poverty and to provide educational services | Miscellaneous |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Propuli GmbH | |
GE Vernova
 GE Vernova Electrical ProductsProducer Manufacturing Generates, transfers and orchestrates, converts & stores gas, nuclear, hydro, steam and wind energy | Producer Manufacturing |
